Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A/VPF-induced pathological angiogenesis

Journal of Histochemistry and Cytochemistry

Volumn 59, Issue 5, 2011, Pages 463-473

  Fu, Yineng ^a   Nagy, Janice A ^a   Brown, Lawrence F ^a   Shih, Shou Ching ^a   Johnson, Pamela Y ^b   Chan, Christina K ^b   Dvorak, Harold F ^a   Wight, Thomas N ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

ADAMTS 1; Angiogenesis; DPEAAE; Endothelium; MMP 15 (MT 2 MMP); VEGF A VPF; Versican

Indexed keywords

ADAMTS1 PROTEIN; ADENOVIRUS VECTOR; GROWTH FACTOR; MATRIX METALLOPROTEINASE 15; PROTEINASE; VASCULOTROPIN A; VERSICAN; ADAM PROTEIN; ADAMTS1 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UPREGULATION; VENULE; WESTERN BLOTTING; ADENOVIRUS; ANIMAL; BIOSYNTHESIS; CELL CULTURE; GENETICS; HUMAN; METABOLISM; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SKIN; VASCULAR ENDOTHELIUM; VASCULARIZATION;

MUS;

ADAM PROTEINS; ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 15; MICE; MICE, NUDE; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VERSICANS;

EID: 79958845515     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155411401748     Document Type: Article

References (46)

1. Apte SS. 2009. A disintegrin-like and metalloprotease (reprolysintype) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J Biol Chem. 284:31493-31497.
2. Bode-Lesniewska B, Dours-Zimmermann MT, Odermatt BF, Briner J, Heitz PU, Zimmermann DR. 1996. Distribution of the large aggregating proteoglycan versican in adult human tissues. J Histochem Cytochem. 44:303-312.
3. Bongrazio M, Baumann C, Zakrzewicz A, Pries AR, Gaehtgens P. 2000. Evidence for modulation of genes involved in vascular adaptation by prolonged exposure of endothelial cells to shear stress. Cardiovasc Res. 47:384-393.
4. Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF. 1999. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res. 5:1041-1056.
5. Canals F, Colome N, Ferrer C, Plaza-Calonge Mdel C, Rodriguez- Manzaneque JC. 2006. Identification of substrates of the extracellular protease ADAMTS1 by DIGE proteomic analysis. Proteomics. 6(suppl 1):S28-S35.
6. Cattaruzza S, Schiappacassi M, Ljungberg-Rose A, Spessotto P, Perissinotto D, Morgelin M, Mucignat MT, Colombatti A, Perris R. 2002. Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J Biol Chem. 277:47626-47635.
7. Chang SH, Kanasaki K, Gocheva V, Blum G, Harper J, Moses MA, Shih SC, Nagy JA, Joyce J, Bogyo M, et al. 2009. VEGFA induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement. membrane degradation and mother vessel formation. Cancer Res. 69:4537-4544.
8. Chang Y, Yanagishita M, Hascall VC, Wight TN. 1983. Proteoglycans synthesized by smooth muscle cells derived from monkey (Macaca nemestrina) aorta. J Biol Chem. 258:5679-5688.
9. Chun TH, Sabeh F, Ota I, Murphy H, McDonagh KT, Holmbeck K, Birkedal-Hansen H, Allen ED, Weiss SJ. 2004. MT1- MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol. 167:757-767.
10. Dvorak HF. 2002. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol. 20:4368-4380.
11. Dvorak HF, Brown LF, Detmar M, Dvorak AM. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 146:1029-1039.
12. Ferrara N. 1999. Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 77:527-543.
13. Genis L, Galvez BG, Gonzalo P, Arroyo AG. 2006. MT1-MMP: universal or particular player in angiogenesis? Cancer Metastasis Rev. 25:77-86.
14. Gustavsson H, Tesan T, Jennbacken K, Kuno K, Damber JE, Welen K. 2010. ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors. BMC Cancer. 10:288.
15. Halpert I, Sires U, Potter-Perigo S, Wight TN, Shapiro DS, Welgus HG, Wickline SA, Parks WC. 1996. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localized to areas of versican deposits. Proc Natl Acad Sci USA. 93:9748-9753.
16. Hatipoglu OF, Hirohata S, Cilek MZ, Ogawa H, Miyoshi T, Obika M, Demircan K, Shinohata R, Kusachi S, Ninomiya Y. 2009. ADAMTS1 is a unique hypoxic early response gene expressed by endothelial cells. J Biol Chem. 284:16325-16333.
17. Iruela-Arispe ML, Carpizo D, Luque A. 2003. ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci. 995:183-190.
18. Kenagy RD, Fischer JW, Davies MG, Berceli SA, Hawkins SM, Wight TN, Clowes AW. 2002. Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts. Arterioscler Thromb Vasc Biol. 22: 400-404.
19. Kenagy RD, Plaas AH, Wight TN. 2006. Versican degradation and vascular disease. Trends Cardiovasc Med. 16:209-215.
20. Kern CB, Norris RA, Thompson RP, Argraves WS, Fairey SE, Reyes L, Hoffman S, Markwald RR, Mjaatvedt CH. 2007. Versican proteolysis mediates myocardial regression during outflow tract development. Dev Dyn. 236:671-683.
21. Kinsella MG, Tsoi CK, Järveläinen HT, Wight TN. 1997. Selective expression and processing of biglycan during migration of bovine aortic endothelial cells: the role of endogenous basic fibroblast growth factor. J Biol Chem. 272:318-325.
22. Krampert M, Kuenzle S, Thai SN, Lee N, Iruela-Arispe ML, Werner S. 2005. ADAMTS1 proteinase is up-regulated in wounded skin and regulates migration of fibroblasts and endothelial cells. J Biol Chem. 280:23844-23852.
23. Lafleur MA, Handsley MM, Knauper V, Murphy G, Edwards DR. 2002. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J Cell Sci. 115:3427-3438.
24. Lemire JM, Braun KR, Maurel P, Kaplan ED, Schwartz SM, Wight TN. 1999. Versican/PG-M isoforms in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 19:1630-1639.
25. Luque A, Carpizo DR, Iruela-Arispe ML. 2003. ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF 165. J Biol Chem. 278:23656-23665.
26. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR. 1998. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol. 202:56-66.
27. Nagy JA, Dvorak AM, Dvorak HF. 2007. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol. 2:251-275.
28. Nagy JA, Shih SC, Wong WH, Dvorak AM, Dvorak HF. 2008. Chapter 3. The adenoviral vector angiogenesis/lymphangiogenesis assay. Methods Enzymol. 444:43-64.
29. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Manseau EJ, Dvorak AM, Dvorak HF. 2002. VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis, and vascular malformations. Cold Spring Harb Symp Quant Biol. 67:227-237.
30. Passi A, Negrini D, Albertini R, Miserocchi G, De Luca G. 1999. The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema. FEBS Lett. 456:93-96.
31. Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, et al. 2000. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest. 80:99-115.
32. Richard L, Velasco P, Detmar M. 1998. A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells. Exp Cell Res. 240:1-6.
33. Rodriguez-Manzaneque JC, Milchanowski AB, Dufour EK, Leduc R, Iruela-Arispe ML. 2000. Characterization of METH-1/ADAMTS1 processing reveals two distinct active forms. J Biol Chem. 275:33471-33479.
34. Russell DL, Doyle KM, Ochsner SA, Sandy JD, Richards JS. 2003. Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation. J Biol Chem. 278:42330-42339.
35. Sandy JD. 2006. A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. Osteoarthritis Cartilage. 14:95-100.
36. Sandy JD, Westling J, Kenagy RD, Iruela-Arispe ML, Verscharen C, Rodriguez-Mazaneque JC, Zimmermann DR, Lemire JM, Fischer JW, Wight TN, et al. 2001. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem. 276:13372-13378.
37. Schönherr E, Jävelänen HT, Sandell LJ, Wight TN. 1991. Effects of platelet-derived growth factor and transforming growth factor-b 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem. 266:17640-17647.
38. Shih SC, Zukauskas A, Li D, Liu G, Ang LH, Nagy JA, Brown LF, Dvorak HF. 2009. The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis. Cancer Res. 69:3272-3277.
39. Somerville RP, Oblander SA, Apte SS. 2003. Matrix metalloproteinases: old dogs with new tricks. Genome Biol. 4:216.
40. Swayne GT, Smaje LH, Bergel DH. 1989. Distensibility of single capillaries and venules in the rat and frog mesentery. Int J Microcirc Clin Exp. 8:25-42.
41. Vazquez F, Hastings G, Ortega MA, Lane TF, Oikemus S, Lombardo M, Iruela-Arispe ML. 1999. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem. 274:23349-23357.
42. Xu Z, Yu Y, Duh EJ. 2006. Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling. Invest Ophthalmol Vis Sci. 47:4059-4066.
43. Yamamura H, Zhang M, Markwald RR, Mjaatvedt CH. 1997. A heart segmental defect in the anterior-posterior axis of a transgenic mutant mouse. Dev Biol. 186:58-72.
44. Yao LY, Moody C, Schönherr E, Wight TN, Sandell LJ. 1994. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol. 14:213-225.
45. Yokoyama H, Wada T, Kobayashi K, Kuno K, Kurihara H, Shindo T, Matsushima K. 2002. A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-1 null mutant mice develop renal lesions mimicking obstructive nephropathy. Nephrol Dial Transplant. 17(suppl 9):39-41.
46. Zhang X, Kazerounian S, Duquette M, Perruzzi C, Nagy JA, Dvorak HF, Parangi S, Lawler J. 2009. Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. Faseb J. 23:3368-3376.